Betterlife Pharma Inc (BETR.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
| 01-2023 | 10-2022 | 07-2022 | 04-2022 | 01-2022 | |
| Operating Expenses | 680 | 4,346 | 1,210 | 3,022 | 2,132 |
| Operating Income | -680 | -4,346 | -1,210 | -3,022 | -2,132 |
| Interest Expense | 8 | 20 | 20 | 19 | 10 |
| Other Income | 108 | -313 | 105 | 52 | -1,631 |
| Pre-tax Income | -580 | -4,679 | -1,125 | -2,989 | -3,772 |
| Net Income Continuous | -580 | -4,679 | -1,125 | -2,989 | -3,938 |
| Minority Interests | N/A | N/A | 2 | N/A | N/A |
| Net Income | $-223 | $-4,679 | $-1,123 | $-2,989 | $-3,938 |
| EPS Basic Total Ops | 0.00 | -0.05 | -0.01 | -0.04 | -0.05 |
| EPS Basic Continuous Ops | 0.00 | -0.05 | -0.01 | -0.04 | -0.05 |
| EPS Diluted Total Ops | 0.00 | -0.05 | -0.01 | -0.04 | -0.05 |
| EPS Diluted Continuous Ops | 0.00 | -0.05 | -0.01 | -0.04 | -0.05 |
| EBITDA(a) | $-568 | $-4,654 | $-1,101 | $-2,965 | $-3,757 |